The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vashkevich A.A.

North-Western State Medical University named after I.I. Mechnikov

Raznatovsky K.I.

North-Western State Medical University named after I.I. Mechnikov

Tomasheva A.O.

Mechnikov North-Western State Medical University

Dulaev A.K.

Pavlov First Saint Petersburg State Medical University

Gvenetadze V.V.

Pavlov First Saint Petersburg State Medical University

Reztsova P.A.

North-Western State Medical University named after I.I. Mechnikov

Kornisheva V.G.

North-Western State Medical University named after I.I. Mechnikov

Kotrekhova L.P.

Mechnikov North-Western State Medical University

Gulordava M.D.

North-Western State Medical University named after I.I. Mechnikov

Klibson S.K.

North-Western State Medical University named after I.I. Mechnikov

Neurofibromatosis type 1: a clinical case

Authors:

Vashkevich A.A., Raznatovsky K.I., Tomasheva A.O., Dulaev A.K., Gvenetadze V.V., Reztsova P.A., Kornisheva V.G., Kotrekhova L.P., Gulordava M.D., Klibson S.K.

More about the authors

Read: 5670 times


To cite this article:

Vashkevich AA, Raznatovsky KI, Tomasheva AO, et al. . Neurofibromatosis type 1: a clinical case. Russian Journal of Clinical Dermatology and Venereology. 2022;21(6):758‑764. (In Russ.)
https://doi.org/10.17116/klinderma202221061758

Recommended articles:
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
Primary bile acid synthesis diso­rders. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):71-90
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33
Sacral dysmorphism in patients with traumatology and orthopedics. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(2):30-37

References:

  1. Borofsky S, Levy LM. Neurofibromatosis: Types 1 and 2. American Journal of Neuroradiology. 2013;34(12):2250-2251. https://doi.org/10.3174/ajnr.A3534
  2. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. 2010. Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. Am J Med Genet. Part A 152A:327-332.  https://doi.org/10.1002/ajmg.a.33139
  3. Gareth Evans, Naomi L Bowers, et al. Schwannomatosis: a genetic and epidemiological study, J Neurol Neurosurg Psychiatry. 2018;89(11):1215-1219. https://doi.org/10.1136/jnnp-2018-318538
  4. Germaine L Defendi. Genetics of Neurofibromatosis Type 1 and Type 2. Medscape. 2020, Aug 10. 
  5. Friedman JM. Neurofibromatosis 1. 1998, Oct 2. (Updated 2019 Jun 6). In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle (WA): University of Washington, Seattle. Seattle (WA): University of Washington, Seattle; 1993-2022. https://www.ncbi.nlm.nih.gov/books/NBK1109/#_nf1_References_
  6. Evans DG. Neurofibromatosis 2. Initial Posting: October 14, 1998 ( Last Update: March 15, 2018). Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 1993-2022. https://www.ncbi.nlm.nih.gov/books/NBK1201/
  7. Evans DG, Baser ME, O’Reilly B, et al. Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg. 2005;19(1):5-12.  https://doi.org/10.1080/02688690500081206
  8. DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000; 105(3 Pt 1):608-614.  https://doi.org/10.1542/peds.105.3.608
  9. Bruce Korf, Scott R. Plotkin, et al. Cutaneous neurofibromas. Current clinical and pathologic issues. Neurology. 2018;91(2 suppl 1):5-13.  https://doi.org/10.1212/WNL.0000000000005792
  10. Pasmant E, Ortonne N, Rittié L, et al. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis. J Neuropathol Exp Neurol. 2010;69(1):60-69.  https://doi.org/10.1097/NEN.0b013e3181c79bff
  11. David T Hsieh. Neurofibromatosis Type 1 Clinical Presentation. Medscape. Apr 23, 2020.
  12. Hivelin M, Wolkenstein P, Lepage C, et al. Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patients. Plast Reconstr Surg. 2010;125(4):1197-1207. https://doi.org/10.1097/PRS.0b013e3181d180e9
  13. Listernick R, Ferner RE, Liu, GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations. Ann Neurol. 2007;61(3):189-198.  https://doi.org/10.1002/ana.21107
  14. Diggs-Andrews KA, Brown JA, Gianino SM, et al. Sex is a major determinant of neuronal dysfunction in neurofibromatosis type1. Ann Neurol. 2014; 75(2):309-316.  https://doi.org/10.1002/ana.24093
  15. Andrew A Dahl. Ophthalmologic Manifestations of Neurofibromatosis Type 1 (NF-1). Medscape. Jul 15, 2021.
  16. Gómez Moyano E, Martínez Pilar L, Rodriguez Calvo de Mora M, et al. Using dermoscopy to assess diagnostic criteria of neurofibromatosis. J Am Acad Dermatol. 2015;73(1):e17-18.  https://doi.org/10.1016/j.jaad.2015.03.053
  17. Crawford AH, Schorry EK. Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg. 1999;7(4):217-230.  https://doi.org/10.5435/00124635-199907000-00002
  18. Wozniak W, Karwacki MW. Is «watchful waiting» superior to surgery in children with neurofibromatosis type 1 presenting with extracranial and extramedullary tumor mass at diagnosis? Childs Nerv Syst. 2008;24(12): 1431-1436.
  19. Seop Park Y. Spinal deformity in neurofibromatosis: Classification and management. J Spine. 2014;3:1-5.  https://doi.org/10.4172/2165-7939.1000186
  20. Yoshida Y, Ehara Y, Koga M, Imafuku S, Yamamoto O. Epidemiological analysis of major complications requiring medical intervention in patients with neurofibromatosis 1. Acta Derm Venereol. 2018;98:753-756.  https://doi.org/10.1111/1346-8138.13902
  21. Feldman DS, Jordan C, Fonseca L. Orthopaedic manifestations of neurofibromatosis type 1. J Am Acad Orthop Surg. 2010;18:346-357.  https://doi.org/10.5435/00124635-201006000-00007
  22. Le C, Bedocs PM. Neurofibromatosis. [Updated 2020 Aug 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.  https://www.ncbi.nlm.nih.gov/books/NBK459329/
  23. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51-57. 
  24. Shah KN. The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin North Am. 2010;57:1131-1153. https://doi.org/10.1016/j.pcl.2010.07.002
  25. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best. JAMA. 2002;287(11):1427-1434. https://doi.org/10.1001/jama.287.11.1427
  26. Karagiannis A, Mikhailidis DP, Athyros VG & Harsoulis F 2007 Pheochromocytoma: an update on genetics and management. Endocrine-Related Cancer. 14;935-956.  https://doi.org/10.1677/ERC-07-0142
  27. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007;3(2):92-102.  https://doi.org/10.1038/ncpendmet0396
  28. Prada CE, Hufnagel RB, Hummel TR, et al. The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr. 2015;167:851-856.  https://doi.org/10.1016/j.jpeds.2015.07.001

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.